Antagonistic effects of S 22153, a new mt1 and MT2 receptor ligand, on the neophobia-reducing properties of melatonin in BALB/c mice

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 1, 1999, Pages 131-136

  Kopp, C ^a   Vogel, E ^a   Rettori, M C ^b   Delagrange, P ^b   Renard, P ^b   Lesieur, D ^c   Misslin, R ^a  

^a Lab d'Ethologie et de Neurobiologie   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c Lab Microbiologie Lab P   (France)

Author keywords

Anxiety; Free exploratory paradigm; Melatonin; Mice; Neophobia

Indexed keywords

MELATONIN; MELATONIN RECEPTOR; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; S 22153; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; MALE; MOUSE; NEOPHOBIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; LIGANDS; MALE; MELATONIN; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; THIOPHENES; TIME FACTORS;

EID: 0032834589     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00071-4     Document Type: Article

References (29)

1. Alberterson T.E., Peterson S.L., Stark L.G., Lakin M.L., Winters W.D. The anticonvulsant properties of melatonin on kindled seizures in rats. Neuropharmacology. 20:1981;61-66.
2. Armstrong S.M., Cassone V.M., Chesworth M.J., Redman J.R., Short R.V. Synchronization of mammalian circadian rhythms by melatonin. J. Neural Transm. Suppl. 21:1986;375-394.
3. Axelrod A. The pineal gland. A neurochemical transducer Science. 184:1974;1341-1342.
4. Bartness T.J., Goldman B.D. Mammalian pineal melatonin. A clock for all seasons Experientia. 45:1989;939-945.
5. Belzung C., Le Pape G. Comparison of different behavioral test situations used in psychopharmacology for the measurement of anxiety. Pharmacol. Biochem. Behav. 28:1994;29-33.
6. Belzung C., Berton F. Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety. Behav. Pharmacol. 8:1997;541-548.
7. Datta P.C., King M.G. Effects of melanocyte-stimulating hormone (MSH) and melatonin on passive avoidance and on emotional response. Pharmacol. Biochem. Behav. 6:1977;449-452.
8. Datta P.C., King M.G. Effects of MIF-I and melatonin on novelty-induced defecation and associated plasma 11-OHCS and brain catecholamines. Pharmacol. Biochem. Behav. 11:1979;173-181.
9. Datta P.C., King M.G. Alpha-MSH, MIF-I and melatonin. Effects on novelty-induced defecation, plasma 11-OHCS and central catecholamines in rats Peptides. 2(Suppl. 1):1981;143-154.
10. Delagrange P., Ting K.N., Kopp C., Lahaye C., Lesieur D., Weibel L., Bennejean C., Renard P., Rettori M.C. In-vitro and in-vivo antagonist properties of S 22153, a new melatonin ligand. Fundam. Clin. Pharmacol. 13(2):1999;253.
11. Golombek D.A., Martini M., Cardinali D.P. Melatonin as an anxiolytic in rats. Time dependence and interaction with the central GABAergic system Eur. J. Pharmacol. 237:1993;231-236.
12. Golombek D.A., Pevet P., Cardinali D.P. Melatonin effects on behavior. Possible mediation by the central GABAergic system Neurosci. Biobehav. Rev. 20:1996;403-412.
13. Golus P., King M.G. The effects of melatonin on open field behavior. Pharmacol. Biochem. Behav. 15:1981;883-885.
14. Griebel G., Belzung C., Misslin R., Vogel E. The free-exploratory paradigm. An effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs Behav. Pharmacol. 4:1993;637-644.
15. Hughes R.N. Behaviour of male and female rats with a free choice of two environments differing in novelty. Anim. Behav. 16:1968;92-96.
16. Karsch F.J., Bittman E.L., Foster D.L., Goodman R.L., Legan S.J., Robinson J.E. Neuroendocrine basis of seasonal reproduction. Recent Prog. Horm. Res. 40:1984;185-232.
17. Kopp, C.; Vogel, E.; Rettori, M. C.; Delagrange, P.; Guardiola-Lemaitre, B.; Misslin, R.: Effects of melatonin on neophobic responses in different strains of mice. Pharmacol. Biochem. Behav. (in press).
18. Lister R.G. Ethologically-based animal models of anxiety disorders. Pharmacol. Ther. 46:1990;321-340.
19. Liu C., Weaver D.R., Jin X., Shearman L.P., Piechl R.L., Gribkokk V.K., Reppert S.M. Molecular dissection of two distinct actions of melatonin on suprachiasmatic circadian clock. Neuron. 19:1997;91-102.
20. Pévet P. The role of the pineal gland in the photoperiodic control of reproduction in different hamster species. Reprod. Nutr. Dev. 28:1988;443-458.
21. Misslin R., Ropartz P. Effects of lateral amygdala lesions on the responses to novelty in mice. Behav. Proces. 6:1981;329-336.
22. Misslin R., Herzog F., Koch B., Ropartz P. Effects of isolation, handling and novelty on the pituitary-adrenal response in the mouse. Psychoneuroendocrinology. 7(2):1982;217-221.
23. 1A ligands, 8-OH-DPAT and MDL 73005EF, in mice. Neuroreport 1:1267-1270; 1990.
24. Redman J., Armstrong S., Ng K.T. Free-running activity rhythms in the rat. Entrainment by melatonin Science. 219:1983;1089-1091.
25. Reppert S.M., Weaver D.R., Godson C. Melatonin receptors step into light. Cloning and classification of subtypes Trends Pharmacol. Sci. 17:1996;100-102.
26. Reuss S. Components and connections of the circadian timing system in mammals. Cell Tissue Res. 285:1996;353-378.
27. 2 receptor ligands modulate the behaviour of mice in the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;985-995.
28. Sugden D. Psychopharmacological effects of melatonin in mouse and rat. J. Pharmacol. Exp. Ther. 227:1983;587-591.
29. Vanecek J. Cellular mechanisms of melatonin action. Physiol. Rev. 78:1998;687-721.